The short version of Cardarine fits in a sentence. The long version — which is the one that helps — is below.
This page was last updated on 2026-04-05 and is reviewed periodically as new material appears.
Regulatory treatment varies, but cardarine is not approved as a medicine. Sports authorities list GW501516 as a prohibited substance, and it is banned at all times under the World Anti-Doping Agency code. Many countries restrict sales for human consumption, while online vendors market it as a research chemical. Such products may lack purity data, and their actual contents can differ from the label. Purchasing or possessing cardarine may carry legal consequences depending on jurisdiction. The compound is not a dietary supplement ingredient in regulated markets.
Clinical development stopped after rodent studies showed tumors at multiple sites. Whether those findings predict human cancer risk remains an open question, but they led sponsors to discontinue programs. Human safety data are limited to small, short-term studies that were not designed to assess cancer risk. Reported effects in those studies included changes in blood lipids, but the evidence is insufficient for medical use. Long-term consequences of nonmedical use are not well characterized. Questions about dose, duration, and individual susceptibility remain unresolved.
Legal status varies by country. In some places, cardarine is controlled under medicines or psychoactive substances laws; in others, it may be sold with minimal oversight as a research chemical. Customs agencies have intercepted shipments, and several national health agencies have issued warnings about products marketed for bodybuilding or performance enhancement. The lack of a standardized pharmaceutical supply means identity, purity, and contamination levels can differ widely between samples. These factors make cardarine a regulatory and public health concern rather than a conventional prescription drug.
Cardarine is a common name for GW501516, a synthetic compound first described in the 1990s as a selective agonist of the peroxisome proliferator-activated receptor delta. It was studied in preclinical models for metabolic and cardiovascular conditions, but it has not been approved as a medicine in the United States, Europe, or other major jurisdictions. Retail products labeled as cardarine are generally research chemicals or supplements, not pharmaceutical formulations. Because human safety and efficacy data remain limited, regulatory agencies treat it as an unapproved substance rather than a therapeutic product.
| Property | Value | Notes |
|---|---|---|
| Common synonyms | GW501516; GW-1516; endurobol | GW501516 is the research code |
| Drug class | PPARδ agonist | Not a selective androgen receptor modulator |
| Molecular formula | C21H18F3NO3S2 | Established chemical formula |
| Molar mass | 453.5 g/mol | Calculated from the formula |
| Regulatory status | Prohibited in sport; not approved as medicine | Status varies by country |
A common misconception is that cardarine has been proven safe for human use. In reality, human clinical data are limited, and long-term animal studies have raised concerns about cancer. Another misconception is that it is a supplement or vitamin-like compound. It is a synthetic research chemical with no approved medical indication. Scientific discussion often focuses on its mechanism and detection rather than therapeutic use. Regulatory and anti-doping literature treats it primarily as a prohibited substance.
Cardarine is explicitly prohibited by the World Anti-Doping Agency under the class of PPARδ agonists. Its presence in urine or blood samples can be detected using mass spectrometry-based methods, often liquid chromatography-tandem mass spectrometry. Athletes who test positive may face sanctions, including bans from competition. The compound is also regulated as a prescription-only or unapproved drug in many countries. Enforcement varies by jurisdiction, and some regions treat it as a controlled substance. Online sales may occur despite these restrictions, creating quality and legal risks.
Products sold as cardarine have been found to contain incorrect compounds, variable amounts, or no active ingredient at all. Independent testing is required to verify identity and purity. Common analytical approaches include high-performance liquid chromatography, mass spectrometry, and nuclear magnetic resonance for structural confirmation. These methods can distinguish GW501516 from related PPAR agonists and from unrelated steroids. For regulators and researchers, such verification is central to interpreting both biological results and adverse event reports.
Cardarine is prohibited in competitive sport under the World Anti-Doping Agency code, where it is classified as a metabolic modulator. It is not approved as a prescription medicine in the United States, European Union, or other major markets. Regulatory action has focused on its presence in sports and in products marketed as research chemicals. Because it has no accepted medical indication, supply is often unregulated. This status creates legal and safety uncertainties for anyone who encounters the substance.
Anti-doping laboratories detect GW501516 and its metabolites using liquid chromatography-tandem mass spectrometry. Urine is the most common matrix, though blood and dried blood spots may also be used in some programs. Detection depends on factors such as dose, timing, metabolism, and the sensitivity of the assay. Published methods describe limits of detection in the low nanogram per milliliter range for related compounds. Exact detection windows are not fixed for all situations and remain an area of ongoing study.
Safety concerns emerged from long-term animal studies. In rodents given the compound for extended periods, researchers found an increased incidence of certain cancers, including liver and bladder tumors. These findings contributed to the discontinuation of clinical development. Whether similar risks apply to short-term or low-level exposure in humans is not established, and controlled human safety data are limited. The relevance of high-dose rodent carcinogenicity findings to human use remains a subject of debate.
Human trials of GW501516 were small and short in duration. They examined lipid levels, glucose handling, and other metabolic markers, but the programs were halted after the animal cancer findings. No approved therapeutic product exists, and published human data are insufficient for establishing long-term safety. Reports of use for athletic performance come mainly from non-clinical settings and cannot be verified through controlled trials. Independent testing of products sold as cardarine has found inconsistent purity and labeling.
Laboratory studies indicate that GW501516 activates PPARδ, a nuclear receptor involved in fatty acid oxidation and energy metabolism. In rodent experiments, treated animals often showed increased endurance and reduced fat mass. These effects were observed under controlled conditions and do not establish safe or effective use in humans. The exact dose-response relationship in humans remains poorly characterized. Species differences in metabolism can affect how results translate across animals and people.
The norepinephrine transporter is composed of 12 transmembrane domains (TMDs). The intracellular portion contains an amino (-NH2) group and carboxyl (-COOH) group. In addition, there is a large extracellular loop located between TMD 3 and 4. The protein is composed of 617 amino acids.
Presumptive testing always precedes analysis of a questioned sample. Most presumptive tests involve a chemical reaction that results in a colour change that is detectable with the plain eye. Thorough documentation of the scene through notes, photographs etc. must be done prior to any presumptive or confirmatory testing in order to maintain chain of custody and avoid contamination. The Griess test and Walker test are two presumptive tests that can be used to determine if a questioned sample contains nitrites. The Walker test is used to determine GSR area on clothing using naphthylamine-sulfanilic acid soaked photograph paper. Red colouration appears when nitrite ions are present. A variant of the Griess test reagent is sulfanilamide and naphthylamine in an acidic medium. The Modified Griess test detects nitrite compounds, which are a by-product of the combustion of gunpowder. Forensic examiners use this test to determine the gun to target distance. This test is performed first because it does not interfere with the later sodium rhodizonate test. The presence of nitrite ions is what triggers the colour change, and therefore we do not consider this test to be indicative of GSR. The sodium rhodizonate test can detect the presence of lead and barium; it results in a red or purple color when lead is present in the tested area, and a reddish-brown colour when exposed to barium. It is an extremely sensitive, specific, and efficient method as it can obtain information on the origin of particulate debris, and it can be done on surfaces or objects.
Glycogen is a molecular polymer of glucose (a polysaccharide) used to store energy, and is important for maintaining glucose homeostasis in the blood, as well as for providing energy for skeletal muscle and cardiac muscle contraction. Molecules of glucose are linked into linear chains by α-1,4-glycosidic bonds. Additionally, branches of glucose are formed off of the chain by α-1,6-glycosidic bonds. 2 molecules of glucose are joined into an α-1,4-glycosidic bonds by an enzyme known as glycogen synthase. This bond may be broken by glycogen phosphorylase when the body wishes to break down glycogen into glucose for energy. Glycogen branching enzyme is responsible for the required α-1,6-glycosidic bonds needed to start a branch off of these linear chains. Any disruption to this system results in a glycogen storage disease. There are currently 2 subcategories of glycogen storage diseases in horses: Type 1 polysaccharide storage myopathy, glycogen branching enzyme deficiency, and Type 2 polysaccharide storage myopathy.
1993/1130) Dundee Teaching Hospitals National Health Service Trust (Appointment of Trustees) Order 1993 (S.I. 1993/1131) Caithness and Sutherland National Health Service Trust (Appointment of Trustees) Order 1993 (S.I. 1993/1132) Southern General Hospital National Health Service Trust (Appointment of Trustees) Order 1993 (S.I. 1993/1133) Stirling Royal Infirmary National Health Service Trust (Appointment of Trustees) Order 1993 (S.I. 1993/1134) Victoria Infirmary National Health Service Trust (Appointment of Trustees) Order 1993 (S.I. 1993/1135) West Lothian National Health Service Trust (Appointment of Trustees) Order 1993 (S.I. 1993/1136) Yorkhill National Health Service Trust (Appointment of Trustees) Order 1993 (S.I. 1993/1137) North Ayrshire and Arran National Health Service Trust (Appointment of Trustees) Order 1993 (S.I. 1993/1138) Monklands and Bellshill Hospitals National Health Service Trust (Appointment of Trustees) Order 1993 (S.I. 1993/1139) Ayrshire and Arran Community Health Care National Health Service Trust (Appointment of Trustees) Order 1993 (S.I. 1993/1140) Essex and Greater London (County and London Borough Boundaries) Order 1993 (S.I. 1993/1141) Croydon, Lambeth and Southwark (London Borough Boundaries) Order 1993 (S.I. 1993/1147) Greater London and Surrey (County and London Borough Boundaries) Order 1993 (S.I. 1993/1148) Coast Protection (Variation of Excluded Waters) Regulations 1993 (S.I. 1993/1149) Income-related Benefits Schemes (Miscellaneous Amendments) (No. 2) Regulations 1993 (S.I.
=== Synthetic ionophores === Many synthetic ionophores are based on crown ethers, cryptands, and calixarenes. Pyrazole-pyridine and bis-pyrazole derivatives have also been synthesized. These synthetic species are often macrocyclic. Some synthetic agents are not macrocyclic, e.g. carbonyl cyanide-p-trifluoromethoxyphenylhydrazone. Even simple organic compounds, such as phenols, exhibit ionophoric properties. The majority of synthetic receptors used in the carrier-based anion-selective electrodes employ transition elements or metalloids as anion carriers, although simple organic urea- and thiourea-based receptors are known.
Sources: en.wikipedia.org
=== Films and documentaries === In 2005, the Mendonça was adapted and released in the movie "Alice", directed by Marco Martins. It was the winner of the Regards Jeunes award in the Cannes Festival in 2005. In 2019, Mendonça was mentioned in the Netflix documentary, The Disappearance of Madeline McCann. In June 2019, the production of a movie inspired in Mendonça and other missing children was announced, Sombra - Uma Mãe Sabe (Shadow - A Mom Knows). It was also announced that the recording would start in September and would end in November 2019. The script was written by Bruno Gascon. The movie Patrick (2019), directed by Gonçalo Waddington was also compared with the Mendonça case.
== Personal life == Alwyn and Aaron Davey are cousins of Brownlow medallist Gavin Wanganeen. Alwyn was named after his father. Davey's twin sons, Alwyn Jr and Jayden were drafted to Essendon in the 2022 AFL draft, under the father–son rule.
== Adverse effects == The adverse effects of synthetic drugs are hard to determine as they usually contain other chemicals with variable concentrations and human studies are limited. Synthetic cannabinoids can cause cardiovascular problems such as tachyarrhythmia, seizures, psychological disorders and potential carcinogenic effects. Addiction and withdrawal symptoms which are linked to chronic use of synthetic cannabinoid include cognitive disturbances (e.g. difficulties in thinking), 'profuse sweating', central nervous system and gastrointestinal disturbances (e.g. nausea and vomiting). The adverse effect of Phenethylamines depends on the type of the drug. 'D series' cause more long-lasting effects than other phenylethylamines such as tachycardia. At high doses, '2C series' produce hallucinogenic and entactogenic effects. Alprazolam can cause central nervous system disturbances and thoughts of suicide.
Parkinson's disease is associated with aggregation of α-synuclein. As O-GlcNAc modification of α-synuclein has been found to inhibit its aggregation, elevating α-synuclein O-GlcNAc is being explored as a therapeutic strategy to treat Parkinson's disease.
== Veterinary use == Oxymorphone provides up to 5–6 hours of clinical analgesia in dogs and cats following intravenous administration. Intramuscular administration in dogs produces approximately 90 minutes of antinociception. Oxymorphone is ineffective when administered via the oral-transmucosal route in cats, likely due to low bioavailability. Only few reports exist on its use in large animal species due to the cost of oxymorphone.
Sources: en.wikipedia.org
Vedolizumab, sold under the brand name Entyvio, is a monoclonal antibody medication developed by Takeda Oncology for the treatment of ulcerative colitis and Crohn's disease. It binds to integrin α4β7 (LPAM-1, lymphocyte Peyer's patch adhesion molecule 1, a dimer of Integrin alpha-4 and Integrin beta-7), blocking the α4β7 integrin results in gut-selective anti-inflammatory activity.
=== Electricity demand and grid capacity === The proliferation of AI has driven a surge in data centre construction and power requirements. According to the National Energy System Operator (NESO), UK data centres consumed 5.0 TWh of electricity in 2023, equivalent to 2% of total UK electricity demand and 7% of commercial sector consumption. However, Oxford Economics forecasts that total demand could grow more than fivefold by 2030, reaching 26.2 TWh, which would represent 8.8% of total UK electricity demand and 30.4% of commercial electricity consumption. This rapid growth has created friction with the UK's net zero targets. In February 2026, the Environmental Audit Committee raised concerns that the government had not adequately factored data centre energy consumption into the draft Seventh Carbon Budget. The energy regulator Ofgem disclosed that developers of new data centres had enquired about grid connections that would require more energy at peak times than the whole of Britain consumes on some days.
=== Bite treatment === First aid involves the application of an ice pack to control inflammation and prompt medical care. If it can be easily captured, the spider should be brought with the patient in a clear, tightly closed container so it may be identified by an arachnologist; if there is no specimen at all, then confirmation by an expert is impossible. Routine treatment should include immobilization of the affected limb, application of ice, local wound care, and tetanus prophylaxis. Many other therapies have been used with varying degrees of success, including hyperbaric oxygen, dapsone, antihistamines (e.g., cyproheptadine), antibiotics, dextran, glucocorticoids, vasodilators, heparin, nitroglycerin, electric shock, curettage, surgical excision, and antivenom. In almost all cases, bites are self-limited and typically heal without any medical intervention. Outpatient palliative care following discharge often consists of a weak or moderate strength opioid (e.g. codeine or tramadol, respectively) depending on pain scores, an anti-inflammatory agent (e.g. naproxen, cortisone), and an antispasmodic (e.g. cyclobenzaprine, diazepam), for a few days to a week. If the pain or spasms have not resolved by this time, a second medical evaluation is generally advised, and differential diagnoses may be considered.
== RBP in pregnancy == Retinol plays a crucial role in the growth and differentiation of various body tissues, and it has been previously characterized that embryos are extremely sensitive to alterations in retinol concentration that can lead to spontaneous abortion and malformations occurring during development. Within a mature animal, retinol is transported from the liver via the circulatory system while bound to RBP to the desired target tissue. RBP is also bound to a carrier protein, transthyretin. The process by which RBP releases retinol for cellular availability is still unknown and not concisely determined.
Multi-seeded and symbiotic fruits: Fruits such as figs are excluded due to their symbiotic relationship with pollinating wasps, which often die inside the fruit. Eggplant (brinjal) is also historically restricted due to its high susceptibility to internal pests and its classification as containing numerous germ-cells (bahu-beej). Fungi and aquatic roots: Mushrooms are strictly excluded as they are non-photosynthetic organisms that grow on decaying matter. Aquatic stems, such as the lotus root, are avoided because their extraction violently disrupts mud-dwelling aquatic organisms. Micro-habitats: Vegetables with dense, overlapping leaves or tight florets, such as cabbage, cauliflower, and broccoli, are traditionally avoided because their complex structures harbor insect colonies that cannot be removed without causing harm. This comprehensive application of nonviolence (ahimsa) also extended beyond food into early forms of ethical consumerism. Historically, Jain ethical codes for the lay community explicitly prohibited participation in the fifteen forbidden trades (karmadanas), which legally barred Jains from manufacturing, selling, or utilizing non-dietary animal products such as leather, ivory, fur, and traditional silk. This strict avoidance of animal byproducts established an ancient historical precedent for the lifestyle practices associated with modern veganism.
Sources: en.wikipedia.org
No. Cardarine is GW501516, a PPARδ agonist, while SARMs act on androgen receptors. The two classes are often grouped in informal discussions despite different mechanisms.
No. It has no approved medical indication in any country. Regulatory agencies have not cleared it for treatment or prevention of any condition.
Early clinical work stopped after rodent carcinogenicity findings. Those animal results raised concerns about long-term human risk, although direct human evidence is lacking. The human relevance of the tumors remains an open scientific question.
No. Major drug regulators have not approved GW501516 for treating any medical condition. Products sold as cardarine are typically unapproved research chemicals or supplements, so their contents and safety are not assured.